slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Funding Update: 2013 – 2015 September 10, 2013 PowerPoint Presentation
Download Presentation
Funding Update: 2013 – 2015 September 10, 2013

Loading in 2 Seconds...

play fullscreen
1 / 11

Funding Update: 2013 – 2015 September 10, 2013 - PowerPoint PPT Presentation


  • 85 Views
  • Uploaded on

Funding Update: 2013 – 2015 September 10, 2013. China 2013. OVERVIEW MR Initiative Annual Expenditure 2001-2013 MR Initiative Annual Donations 2001-2013; Financial Resource Requirements through 2015 MR Initiative Financial Resource Requirements - detail

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Funding Update: 2013 – 2015 September 10, 2013' - nayef


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide3

OVERVIEW

  • MR Initiative Annual Expenditure 2001-2013
  • MR Initiative Annual Donations 2001-2013; Financial Resource Requirements through 2015
  • MR Initiative Financial Resource Requirements - detail
  • MR Initiative donors, 2001 - 2013
  • measles & rubella moving ahead
  • Challenges to implementation for MR Initiative
slide4

MR Initiative Annual Expenditure, 2001-2013

Total expenditure 2001-2013 = $1,008 million

* Excluding country contributions

slide5
Measles & Rubella Initiative Annual Donations 2001-2015 and Financial Resource Requirements, Projections, Funding Gap 2013-2015*

94

59

11

36

38

44

* Excludes all country contributions and direct social mobilization funding from partners

slide6

Measles & Rubella Initiative Financial Resource Requirements, Projections, Funding Gap 2013-2015

47

Total Funding Gap 2014-2015: US $65 million

32

18

31

Anticipated Country Contributions

Anticipated GAVI Contribution (Rubella)

Donor Funds Projected/Pledged/Received

Funding Gap (includes PSC)

resource requirements by major category of activity 2014 2015
Resource Requirements by Major Category of Activity, 2014-2015

TotalCost 2014-2015: US $557 million

mr initiative donors 2001 2013
MR Initiative Donors, 2001-2013

* Includes ARC/UNF and other partners

slide9

Where is the Measles & Rubella Initiative Headed?Toward regional achievement of Measles Rubella Elimination Goals by or before 2020Improvement of routine coverage and timely and high quality SIAsExpanded use of accurate data for decision making

  • 2012 measles goals: AFRO (pre-elimination) and WPRO (elimination) - missed
  • 2013 potential SEARO elimination goal set (waiting), begin MR introduction campaigns with GAVI support (done)
  • 2015GIVS (95% mortality reduction) and MDG 4 goals; measles goal in EMRO and EURO (elimination); rubella goal in EURO (elimination); continue to set regional rubella elimination goals as appropriate
  • 2020 Measlesgoal in AFRO (elimination)

Critical Elements for Success

  • Political leadership
  • Timely funding (donor and national governments)
  • Adequate time for planning and social mobilization (9 months)
  • Well performing surveillance, analysis & use of data to improve coverage
challenges to implementation for mr initiative
Challenges to Implementation for MR Initiative
  • Lack of timely and sufficient funding: few multiyear grants
  • Ensuring high quality SIA’s (increased training and social mobilization cost, increased technical assistance request)
  • Providing strategic support for non-GAVI eligible countries (TA, Surveillance)
  • Increased surveillance cost (including lab, coverage surveys)
  • Projecting target age range for SIA’s several years in advance
  • Projecting cost to MR Initiative for target populations above 59 months for GAVI funded measles SIA’s in 6 large countries
  • Routine immunization: scale up of MCV1, increased MCV2 introduction and coverage, other routine strengthening immunization activities